Oblon has been featured in Attorney at Law on February 14, 2020 – "Oblon Secures No. 1 Ranking for Most Utility Patents in 2019." This post highlights our ranking for securing the most utility patents in 2019 and our recent promoted partners Yuki Onoe and Daniel Pereira, as co-heads of the Chemical Patent Prosecution Group.

Aldo Martinez wrote an article featured in Westlaw IP entitled "The Adversarial Process of Working with Patent Examiners – and How to Speed up a Patent Application."

In Samsung Electronics America, Inc. v. Prisua Engineering Corp., the Fed. Cir. confirmed that, outside of the context of a motion to amend, the PTAB cannot cancel claims for indefiniteness in an IPR proceeding. Specifically, the Court found that if the PTAB cannot ascertain the scope of a claim with reasonable certainty for purposes of assessing patentability, the proper course for the PTAB to follow "is to decline to institute the IPR or, if the indefiniteness issue affects only certain claims, to conclude that it could not reach a decision on the merits with respect to whether petitioner had established the unpatentability of those claims under sections 102 or103. It would not be proper for the Board to cancel claims on a ground that is unavailable in an IPR."

Todd Baker, Lisa Mandrusiak and Chris Riccuiti will be attending the 2020 PTAB Bar Association Annual Conference on March 10-12, 2020.

Oblon is pleased to be a sponsor of the AUTM 2020 Annual Meeting, taking place in San Diego, CA on March 8-11. Jeff McIntyre, James Love and Brendan Roach attend. AUTM's Annual Meeting is the year's signature tech transfer event where professionals from around the world meet to network, make deals and gain valuable insights from world-class speakers and panels.

Eleven Oblon attorneys have been named to the 2020 edition of Best Lawyers in America.

Oblon's Patent Prosecution practice and partners from the firm's Chemical, Electrical & Mechanical and Litigation practices have received top national rankings in the 2019 edition of IAM Patent 1000: The World's Leading Patent Professionals.